课题基金 / 基金详情

项目摘要

项目成果

STELLA PAPPA的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者(PI)可能从另一个NIH来源获得了主要资金, 因此可以在其他CRISP条目中表示。所列机构为 研究中心,而研究中心不一定是研究者所在的机构。 环核苷酸磷酸二酯酶10A(PD 10A)在纹状体中高度表达,在纹状体中它参与与认知和运动功能相关的信号传导机制。近年来,选择性PDE 10A抑制剂已被合成,这些药物的临床前试验已显示出对精神分裂症的显著治疗潜力。 目前,这些药物对其他行为领域的影响还不太清楚。 与其他抗精神病药物一样,评估PDE 10A抑制剂的运动效应尤为重要。这些影响尚未完全表征,我们将在非人类灵长类动物中研究它们。了解这种运动效应不仅有助于我们预测这些药物在精神分裂症临床应用的潜在副作用,还可能使我们发现PDE 10A抑制剂的替代应用。如最近的生理学数据所示,PDE 10A可能主要在纹状体神经元的某些亚群中表达,然后可以被PDE 10A抑制剂选择性靶向。 纹状体中神经元亚群的活动之间的不平衡是运动障碍如帕金森病的病理生理学的核心。 因此,可以想象,PDE 10A抑制剂可能对帕金森病症状显示出疗效。在这个项目中,我们将描述TP-10(一种选择性PDE 10A抑制剂)在灵长类动物中的运动效应。 这是一个新启动的项目。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The cyclic nucleotide phosphodiesterase 10A (PD10A) is highly expressed in the striatum where it participates in signaling mechanisms related to cognitive and motor function. In recent years, selective PDE10A inhibitors have been synthesized, and preclinical tests of these agents have shown significant therapeutic potential for schizophrenia. At this time, the effects of these drugs on other realms of behavior are less clear. As with other antipsychotic drugs, it will be particularly important to evaluate the motor effects of PDE10A inhibitors. These effects are not fully characterized, and we will study them in non-human primates. Knowing such motor effects would not only help us predict potential side effects of the clinical use of these drugs in schizophrenia, but may also lead us to discover alternative applications for PDE10A inhibitors. As indicated by recent physiology data, PDE10A may be expressed predominantly in certain subpopulations of striatal neurons that could then be selectively targeted by PDE10A inhibitors. Imbalances between the activities of neuronal subpopulations in the striatum are at the core of the pathophysiology of movement disorders such as Parkinson's disease. It is therefore conceivable that PDE10A inhibitors may show efficacy against parkinsonian symptoms. In this project, we will characterize the motor effects of TP-10, a selective PDE10A inhibitor, in primates. This is a newly activated project.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NMDA-R2B ANTAGONISTS FOR THE THERAPY OF PARKINSON?S DISEASE
  • 批准号:
    7958259
  • 项目类别:
  • 资助金额:
    $5.48万
  • 财政年份:
    2009
  • 负责人:
    STELLA PAPPA
  • 依托单位:
REGULATION OF MOTOR FUNCTION IN PARKINSON'S DISEASE
  • 批准号:
    7958152
  • 项目类别:
  • 资助金额:
    $5.48万
  • 财政年份:
    2009
  • 负责人:
    STELLA PAPPA
  • 依托单位:
NMDA RECEPTOR AS THERAPEUTIC TARGET FOR PARKINSON?S DISEASE
  • 批准号:
    7958260
  • 项目类别:
  • 资助金额:
    $4.39万
  • 财政年份:
    2009
  • 负责人:
    STELLA PAPPA
  • 依托单位:
REGULATION OF MOTOR FUNCTION IN PARKINSON'S DISEASE
  • 批准号:
    7715724
  • 项目类别:
  • 资助金额:
    $3.56万
  • 财政年份:
    2008
  • 负责人:
    STELLA PAPPA
  • 依托单位:
海外基金